FDA record · 503B outsourcing facility

Park Avenue Compounding: FDA 503B outsourcing facility record

Park Avenue Compounding in St. Louis, MO is on FDA's register of 503B outsourcing facilities. Registered since Dec 23, 2023; last FDA inspection Sep 23, 2025; Form 483 issued at that inspection: Yes; action FDA lists: Regulatory Meeting Held 5/7/2026. Register updated by FDA Sep 30, 2026.

Julian CaraulaniFounder, PriceTracker GLP-1FDA register read Oct 3

Status: Registered since Dec 23, 2023; last FDA inspection Sep 23, 2025.

What FDA’s register states

FDA register entry for Park Avenue Compounding
Field	What FDA’s record states	Source
Facility	Park Avenue Compounding	FDA register
Location	St. Louis, MO	FDA register
First registered	Dec 23, 2023	FDA register
Most recent registration	Nov 19, 2025	FDA register
Last FDA inspection	Sep 23, 2025	FDA register
Form 483 issued	Yes	FDA register
Recall conducted	No	FDA register
Action based on last inspection	Regulatory Meeting Held 5/7/2026	FDA register
Earlier compounding action	Not published by FDA	n/a
Intends to compound sterile drugs from bulk	No	FDA register

Registration is a filing, not an approval.A Form FDA 483 lists what investigators observed; in FDA’s words it “does not constitute a final agency determination of whether any condition is in violation of the FD&C Act or any relevant regulations.” “Open” means FDA has not determined whether further action will be taken.

Source

Copied from FDA’s Registered Outsourcing Facilities table ↗, updated by FDA Sep 30, 2026, read Oct 3, 2026. The table does not include State Board of Pharmacy actions. All 98 registered facilities